Rapid Micro Biosystems (NASDAQ:RPID) Posts Earnings Results, Meets Expectations

Rapid Micro Biosystems (NASDAQ:RPID) announced its quarterly earnings data on Friday. The company reported ($0.22) earnings per share for the quarter, meeting the consensus estimate of ($0.22), Zacks reports. The company had revenue of $8.22 million during the quarter, compared to analysts’ expectations of $8.20 million. Rapid Micro Biosystems had a negative return on equity of 48.05% and a negative net margin of 184.93%. Rapid Micro Biosystems updated its FY 2025 guidance to EPS.

Rapid Micro Biosystems Stock Performance

NASDAQ RPID opened at $3.05 on Friday. The stock has a market cap of $131.25 million, a PE ratio of -2.72 and a beta of 1.25. Rapid Micro Biosystems has a 52-week low of $0.58 and a 52-week high of $4.04. The firm has a 50-day moving average of $1.95 and a 200-day moving average of $1.30.

Analyst Ratings Changes

Separately, KeyCorp assumed coverage on shares of Rapid Micro Biosystems in a report on Wednesday, February 12th. They set an “overweight” rating and a $8.00 target price on the stock.

About Rapid Micro Biosystems

Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.